Micro channel percutaneous nephrolithotripsy in treating upper ureteral calculi complicated with diabetes

Abstract

Objective To assess the efficacy and safety of micro channel percutaneous nephrolithotripsy (MPCNL) for upper ureteral calculi in patients with diabetes. Methods Retrospective investigation was performed on 166 cases of upper ureteral calculi patients who had underwent MPCNL from October 2011 to September 2015 in Luoding People's Hospital, 83 cases of the patients were complicated with diabetes (Diabetes group) and the others without diabetes (Control group). Results There was no statistical difference between the two groups in age, gender, body mass index (BMI), stone size and position (all P>0.05). There was no significant difference between Diabetes group and Control group in operation time [(82.1±28.8) min vs (77.4±30.2) min, P=0.306], decrease of hemoglobin [(1.8±0.7) g/Lvs (1.7±0.6) g/L, P=0.325], systemic inflammatory response syndrome (26.5% vs 22.9%, P=0.719), stone-free rate(92.8% vs 95.2%, P=0.746), hospital stays [(11.2±2.3) d vs (10.8±2.1) d, P=0.244]. Conclusion Micro channel percutaneous nephrolithotripsy is a safe and effective therapy in treating upper ureteral calculi complicated with diabetes. Key words: Micro channel, percutaneous nephrolithotripsy; Upper ureteral calculi; Diabetes